Estrogen and progesterone receptor proteins in breast cancer (Q39841011)

15 September 2017

Estrogen and progesterone receptor proteins in breast cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

27 June 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

progestins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

hormone antagonist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

oestrogen receptor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

progesterone receptor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

27 June 2022

author name string

D. P. Edwards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

G. C. Chamness

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

W. L. McGuire

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A391286

27 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=391286

27 June 2022

publication date

1 December 1979

1 reference

15 September 2017

19 December 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=391286

full work available at URL

27 June 2022

https://api.elsevier.com/content/article/PII:0304419X79900131?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

https://api.elsevier.com/content/article/PII:0304419X79900131?httpAccept=text/plain

27 June 2022

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Biochimica et Biophysica Acta

27 June 2022

published in

1 reference

15 September 2017

560

1 reference

15 September 2017

4

1 reference

15 September 2017

457-486

1 reference

A human cell line from a pleural effusion derived from a breast carcinoma

15 September 2017

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Ablation therapy for hormone-dependent tumors

1

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen-receptor interaction

19 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Female steroid hormones and target cell nuclei

19 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

The Receptors of Steroid Hormones

19 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Specific estrogen-receptors in the neoplastic and lactating mammary gland of the rat

19 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Oestrogen receptors in the mammary gland of the lactating rat

19 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Specific cytoplasmic glucocorticoid hormone receptors in lactating mammary glands.

19 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen Receptor Assay in Human Breast Cancer

19 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Nuclear binding of the estrogen receptor in whole uteri

19 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Isolation and characterization of the nuclear acceptor that binds the progesterone-receptor complex in hen oviduct

19 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression.

19 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors

19 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

23

38

2434

Horwitz

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen and progestogen binders in human and rat mammary carcinoma

19 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

25

37

258

Trams

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

26

37

637

McGuire

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Protamine-precipitated estrogen receptor: A solid-phase ligand exchange assay

19 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Nuclear estradiol receptor in the adult rat uterus: a new exchange assay

19 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

31

37

3329

Garola

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

32

37

3333

Garola

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

33

38

2216

Garola

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Antiestrogens in treatment of breast cancer

19 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

19 April 2023

36

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Content of estrogen receptors in human breast cancer

19 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

38

32

1983

Wittliff

1972

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen receptors in human breast cancer

19 April 2023

39

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women

19 April 2023

41

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrone and estradiol content in human breast tumors: Relationship to estradiol receptors

19 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

43

38

1948

Panko

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Progesterone "receptor" in rabbit uterus. I. Characterization and estradiol-17beta augmentation.

19 April 2023

45

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Oestrogen-induced progesterone receptor in human uterus

19 April 2023

46

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

48

37

1733

Horwitz

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

50

37

464

Pichon

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Progesterone binding in the immature mouse and rat uterus.

19 April 2023

51

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors

19 April 2023

53

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Specific progesterone receptors in human breast cancer

19 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Current status of estrogen and progesterone receptors in breast cancer

19 April 2023

56

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer

19 April 2023

57

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

60

38

3468

Saez

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Hormones in breast cancer: Update 1978

19 April 2023

61

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Oestrogen-responsive human breast cancer in long term tissue culture

19 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

63

37

1901

Lippman

1977

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

64

36

4595

Lippman

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

66

24

389

Goldman

1964

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

67

38

2773

Burke

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from uterus and anterior pituitary.

19 April 2023

73

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth

19 April 2023

74

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Antiestrogen Action in the Uterus: Biological Ineffectiveness of Nuclear Bound Estradiol after Antiestrogen123

19 April 2023

75

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine

19 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

RNA polymerase activity and uterine growth: Differential stimulation by estradiol, estriol, and nafoxidine

19 April 2023

77

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Oestrogen receptors and antagonism of steroid hormone action

19 April 2023

79

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

81

60

1409

Jordan

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

The Effect of Estrogen and Progesterone on Uterine Prostaglandin Biosynthesis in the Ovariectomized Rat

19 April 2023

82

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals.

19 April 2023

83

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen Receptor Translocation and Replenishment by the Antiestrogen Tamoxifen

19 April 2023

84

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Antiestrogen action: differential nuclear retention and extractability of the estrogen receptor

19 April 2023

85

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Different nuclear binding sites for antiestrogen and estrogen receptor complexes.

19 April 2023

86

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Tamoxifen as an anti-tumour agent: effect on oestrogen binding

19 April 2023

88

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effects of oestradiol - 17beta and tamoxifen on total and accessible cytoplasmic oestradiol - 17beta receptors in DMBA-induced rat mammary tumours

19 April 2023

89

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effects of oestradiol-17β and tamoxifen on nuclear oestradiol-17β receptors in DMBA-induced rat mammary tumours

19 April 2023

90

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifen

19 April 2023

91

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

93

34

1971

DeSombre

1974

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Tamoxifen as an anti-tumour agent: role of oestradiol and prolactin

19 April 2023

94

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Anti-oestrogens and breast cancer

19 April 2023

95

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Growth-stimulating effect of Nafoxidine on rat mammary tumor after ovariectomy

19 April 2023

96

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Clomid or nafoxidine administered to neonatal rats causes reproductive tract abnormalities

19 April 2023

98

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumours

19 April 2023

99

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response

19 April 2023

100

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Plasma hormones and pituitary luteinizing hormone in the rat during the early stages of pregnancy and after post-coital treatment with tamoxifen (ICI 46,474)

19 April 2023

101

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Oestrogen synthesis during delayed implantation in the rat

19 April 2023

102

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Inhibition of oestrogen-stimulated prolactin release by anti-oestrogens

19 April 2023

103

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

104

60

1421

Lippman

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Nuclear retention of receptor–oestrogen complex and nuclear acceptor sites

19 April 2023

105

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Estrogen receptors in the rat uterus. Retention of hormone-receptor complexes

19 April 2023

106

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Clinical trial of clomiphene in advanced breast cancer

19 April 2023

107

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Clinical trial of nafoxidine, an oestrogen antagonist in advanced breast cancer

19 April 2023

108

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.

19 April 2023

109

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

19 April 2023

111

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

19 April 2023

112

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Plasma hormones in patients with advanced breast cancer treated with tamoxifen

19 April 2023

113

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course

19 April 2023

114

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

116

60

1431

Lerner

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

118

60

1451

Tormey

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

119

60

1463

Heuson

1976

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

In vivo blockade of the estradiol-binding-protein (EBP) by clomiphene citrate in human breast cancer

19 April 2023

120

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Anti-oestrogens and breast cancer

19 April 2023

121

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor

19 April 2023

122

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Nafoxidine--an antiestrogen for the treatment of breast cancer

19 April 2023

123

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values.A phase II study

19 April 2023

124

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

The effects of Nolvadex (tamoxifen citrate; ICI 46,474) on pregnancy in rabbits

19 April 2023

125

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Inhibition of Tamoxifen of the stimulatory action of FSH on oestradiol-17beta synthesis by rat ovaries in vitro

19 April 2023

126

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

19 April 2023

127

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Oestradiol synthesis from C19 steroids by human breast cancers

19 April 2023

128

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Biosynthesis of 17β-oestradiol in human breast carcinoma tissue and a novel method for its characterization

19 April 2023

129

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Immunofluorescent detection of estrogen receptors in breast cancer.Comparison with dextran-coated charcoal and sucrose gradient assays

19 April 2023

131

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique

19 April 2023

132

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Cytochemical Study of Estrogen Receptor in Human Mammary Cancer

19 April 2023

133

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

In vivo and in vitro immunofluorescent approach to the physiopathology of estradiol kinetics in target cells

19 April 2023

135

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Mammary cancer: selective action of the estrogen receptor complex

19 April 2023

136

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Isolation of lymphoma cell variants resistant to killing by glucocorticoids

19 April 2023

139

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor

19 April 2023

140

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Chromosomal proteins regulate steroid binding to chromatin

19 April 2023

141

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Binding of estradiol receptor complexes to isolated human breast chromatin

19 April 2023

142

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

143

38

59

Bogden

1978

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer

19 April 2023

145

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

146

27

626

McCormick

1967

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat.

19 April 2023

147

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

148

27

626

McCormick

1967

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effect of progesterone and estrogen on DNA synthesis of pregnancy-dependent mammary tumors in GR/A mice

19 April 2023

150

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Treatment of breast cancer with medroxyprogesterone acetate

19 April 2023

151

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Progestin therapy of breast cancer: comparison of agents

19 April 2023

152

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Effect of Lyndiol, an oral contraceptive, on breast cancer

19 April 2023

153

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

Induction of Human Endometrial Estradiol Dehydrogenase by Progestins

19 April 2023

154

1 reference

https://api.crossref.org/works/10.1016/0304-419X(79)90013-1

19 April 2023

Identifiers

1 reference

15 September 2017

1 reference